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Objective To study the effect of metformin on lactate metabolism in 
hepatocytes in vitro under high glucose stress. In vitro LO2 cells, liver 
cells were randomly divided into blank control group, 25 tendency/L 
glucose solution, 27 tendency/L glucose solution, 29 tendency/L glucose 
solution, 31 tendency/L glucose solution, 33 tendency/L glucose solution, 
35 tendency/L glucose solution treatment group, the optimal concentration 
of 31 tendency after L, use 30 tendency for L metformin solution, and then 
divided into blank control group, the optimal concentration of glucose 
solution, normal liver cells + metformin solution normal liver cells. The 
optimal concentration of glucose solution normal liver cells + metformin 
solution respectively in the 12 h, 24 h, 48 h on cell count plate to calculate 
the number of liver cells, and using lactic acid determination kit the 
optimal concentration of glucose solution + normal liver cells and normal 
liver cells + the optimal concentration of glucose solution + metformin 
solution respectively in the 12 h, 24 h, 48 h of cell cultures of lactic acid 
significant increase in the number of surviving hepatocytes in the high-
glycemic control group compared with that in the high-glycemic control 
group without metformin. Metformin has no significant effect on lactic 
acid metabolism of hepatocytes under high glucose stress in vitro, and has 
a protective effect on hepatocytes under high glucose stress. Based on this, 





Metformin associated lactic acidosis (MALA)
1. Introduction
With the change of people’s lifestyle and habits, the in-
cidence of diabetes has been on a straight rise. At present, 
1.01 million new diabetes patients are newly diagnosed 
in China every year. It is predicted that the number will 
reach 59 million in 2025, and more than 90% of the pa-
tients will be type II diabetes mellitus (T2MD) [1-3]. China 
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has the largest number of diabetic patients [4]. Because the 
occurrence and development of diabetes involve a variety 
of factors, the pathogenesis is complex, and there is a va-
riety of damage mechanism interaction, so far there is no 
cure.
Clinically, traditional hypoglycemic drugs have played 
a good role in controlling blood glucose and delaying 
the occurrence of complications, but there are still some 
limitations and adverse reactions. Metformin is an oral 
metformin antidiabetic drug, which is widely used in 
clinic because of its significant hypoglycemic effect and 
multi-faceted clinical application value. Metformin is also 
regarded as the preferred hypoglycemic drug in the world. 
Home and DDP studies have demonstrated the safety 
and efficacy of metformin in the treatment of diabetes [5]. 
However, with the increasing application of metformin in 
clinical practice, some side effects have been gradually 
shown in the use of metformin as a hypoglycemic agent, 
among which lactic acidosis (LA) has been a concern 
of clinicians. Patients taking metformin caused by lac-
tic acidosis, called metformin correlation lactic acidosis 
(MALA), MALA is the use of metformin treatment in the 
process of unusual and severe adverse reactions, is due to 
the metformin hindered the pathways of the lactic acid to 
glucose in the mitochondria, the cause of lactic acid in the 
body to generate too much or too little, caused the body 
to produce the metabolic disorders, the mortality of the 
disease is very high [6-7]. Studies have shown that the lactic 
acidosis caused by metformin may be related to the severe 
diseases of diabetic patients [8], which is mainly related to 
renal insufficiency, cardiac insufficiency and hypoxia of 
patients. Based on this, this paper will elaborate the effects 
of metformin intervention on lactic acid metabolism of 
normal liver cells under high glucose stress in vitro, and 
then explore whether metformin has a direct correlation 
with lactic acid metabolism, so as to provide reference for 
the clinical treatment of diabetes and the rational use of 
metformin.
2. Materials and Methods
2.1 Main Reagents and Instruments
Reagents: LO2 liver cell line, DMEM medium, trypsin, 
penicillin-streptomycin double antibody mixed solution, 
metformin, 10% fetal bovine serum, lactate assay kit (all 
purchased from Haikou Ruike Biological Technology Co., 
Ltd.) were selected.
Instruments: microscope, ultra-clean biological plat-
form, CO2 cell incubator.
2.2 Experimental Methods
2.2.1 Cell culture
LO2 cells with 10% fetal bovine serum DMEM culture 
completely, at 37 ℃ and 5% CO2 incubator in the breed-
ing, cultivation to the cell wall, routine cell culture, 1 ~ 2 
days in a fluid, when the culture cell coverage was 80% ~ 
90%, subculture, repeated operation, will have a bottle of 
the represented the cells cryopreserved, in order to avoid 
accident cause lack of LO2 liver cells to experiment.
2.2.2 Group Model Establishment Control Exper-
iment
2.2.2.1 Establishment of High Glucose Model
Before the beginning of this experiment, LO2 liver 
cells were pretreated with high Glucose, and the optimal 
concentration of Glucose (G) was tested. The concen-
tration gradient of G was set as 0 mmol/L, 25 mmol/L, 
27mmol/L, 29mmol/L, 31 mmol/L, and 33 mmol/L. The 
preexperiment obtained 31 mmol/L as the optimal concen-
tration, and the lactic acid content was measured with the 
lactic acid kit.
2.2.2.2 Establishment of Metformin Model
In this experiment, metformin hydrochloride tablets 
were diluted to 30mmol/L into cell culture medium to pre-
treat LO2 hepatocytes with metformin for 12 h, 24 h and 
48 h.
2.2.2.3 Establishment of Intervention Model
In this experiment, 30mmol/L of metformin hydrochlo-
ride culture solution and 31mmol/L of glucose solution 
were added into the culture flask. After culture for 12 h,24 
h and 48 h, the lactic acid content was measured with the 
lactic acid kit.
2.2.3 Hepatocyte Proliferation was Determined by 
Cell Count Method
Trypsin was used to decompose the cells, and after 
digestion for a period of time, the culture solution was 
added to stop digestion, and then the culture solution was 
transferred to the counting plate with pipetting gun, and 
the cells were counted in strict accordance with the cell 
counting rules.
2.2.4 Lactic Acid in Samples was Detected by Kit 
Method
In addition, metformin solution and high-glucose treat-
ed cell solution were added and put into carbon dioxide 
cell incubator for culture for 12 h, 24 h and 48 h, and the 
lactic acid value in the cell culture medium was measured 
by the lactic acid kit respectively, so as to judge the effect 
DOI: https://doi.org/10.30564/jer.v3i1.2864
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of dimethyldiplastema on cells under high glucose.
2.3 Statistical Methods
Statistical analysis SPSS25.0 statistical software was 
used for data processing. Sample t test was used for sam-
ple mean and one-way analysis of variance was used for 
multiple mean. P < 0.05 was considered statistically sig-
nificant.
3. Results and Analysis
3.1 Selection of the Most Suitable Liver Cells with 
High Glucose Concentration
After this experiment, the most suitable concentration 
of G in LO2 liver cells under high glucose stress was ex-
plored, as shown in Table 1. When the concentration of G 
was 31 mmol/L, the most appropriate concentration was 
found.
3.2 Effects of Metformin on Lactic Acid Metab-
olism of Normal Liver Cells under High Glucose 
Stress
30 mmol/L metformin was prepared in the medium, 
and the control group and the experimental group were 
set. Normal liver cells, high glucose + normal liver cells, 
metformin + normal liver cells, and high glucose + met-
formin + normal liver cells were designed respectively. 
The changes of lactic acid concentration measured at 12 h, 
24 h and 48 h of culture were shown in Table 2.
According to the experimental group and control group, 
the metformin itself does not cause liver cells to produce 
lactic acid, under the environment of high sugar, accord-
ing to the results of the experiment concerning group con-
trast, before adding metformin, the concentration of lactic 
Table 1. Selection of the most suitable liver cells with high glucose concentration (normal liver cells)
The concentration of added glucose (mmol/L) 25 27 29 31 33 35 0
Number of surviving liver cells (12h) 1.12×10*7 1.06×10*7 1.02×10*7 0.98×10*7 0.88×10*7 0.40×10*7 1.30×10*7
Number of surviving liver cells (13h) 2.04×10*7 1.97×10*7 1.95×10*7 1.92×10*8 1.72×10*8 1.25×10*8 2.60×10*7
Number of surviving liver cells (14h) 3.99×10*7 3.92×10*7 3.79×10*9 3.76×10*9 3.63×10*9 3.19×10*9 5.20×10*7
Number of surviving liver cells (15h) 1.68±0.29 2.46±0.79 3.27±1.38 3.48±1.42 4.63±1.63 5.34±2.26 0
Number of surviving liver cells (16h) 3.89±1.42 4.79±1.68 5.24±2.17 5.89±2.64 6.23±2.79 8.98±2.86 0
Number of surviving liver cells (17h) 6.72±2.33 8.43±2.56 9.14±2.99 9.28±3.11 10.87±3.34 11.27±3.39 0
Table 2. Effects of metformin on lactic acid metabolism of normal liver cells under high glucose stress
Group 1 (liver cells in normal group) Group 2 (normal + high glucose)
12h 24h 48h 12h 24h 48h
Add glucose concentration mmol/L / 31
Add metformin concentration (mmol/L) / /
Lactic acid concentration (mmol/L) 0 0 0 3.48±1.42 5.89±2.64 9.28±3.11
Number of surviving liver cells (1) 1.30×10*7 2.60×10*7 5.20×10*7 0.98×10*7 1.92×10*8 3.76×10*9
Group 3 (normal group + metformin) Group 4 (hepatocytes + high glucose + metformin)
12h 24h 48h 12h 24h 48h
Add glucose concentration mmol/L / 31
Add metformin concentration (mmol/L) 30 30
Lactic acid concentration (mmol/L) 0 0 0 3.30±1.39 5.83±2.63 9.17±3.08
Number of surviving liver cells (unit) 1.30×10*7 2.60×10*7 5.20×10*7 1.15×10*7 2.24×10*7 4.79×10*7
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acid in culture medium of high glucose + normal liver 
cells increased from 1.42 mmol/L to 3.48 mmol/L in 12 h, 
and the highest value increased to 5.89 mmol/L after 24 h, 
After 48 h, the increase rate of cell number began to de-
crease significantly, and the lactic acid concentration also 
increased to 9.289 mmol/L, and after adding metformin, 
There were no significant changes in lactate concentration 
and cell number compared with those under high glucose 
stress alone.
4. Discussion
A large number of studies have shown that lactic acido-
sis is a rare and serious complication of diabetic patients, 
most of which occur in patients who take guanidine drugs 
and are accompanied by liver and kidney insufficiency, 
heart failure, etc [9-10]. In recent years, studies have sug-
gested that Metformin Lactate Acidosis (MALA) caused 
by normal therapeutic doses of Metformin is rare, but it 
may also lead to elevated plasma lactic acid levels and 
even Lactate Acidosis (LA) if it is improperly used in 
clinical practice [11]. Liver is an important organ of glucose 
metabolism. Liver can absorb and use glucose to reduce 
blood sugar, and can convert glucose into liver glycogen 
for storage. Patients with cirrhosis have increased insu-
lin resistance, which will affect glucose metabolism and 
cause hepatogenic diabetes. Diabetes can also affect the 
liver, especially patients with type 2 diabetes who are 
prone to liver function damage and non-alcoholic fatty 
liver disease [12]. As a traditional hypoglycemic agent, met-
formin can promote the metabolism of glucose, increase 
its anaerobic colysis, improve the level of lactic acid and 
lead to lactic acidosis. In addition, metformin can inhibit 
the utilization of lactic acid by the liver and muscle and 
inhibit gluconeogenesis, thus reducing the production of 
glucose, and thereby increasing the risk of lactic acid poi-
soning by accumulation of lactic acid [13-15].
In this study, it was found that metformin had little 
effect on the metabolism of lactic acid in liver cells under 
high glucose environment, and there was no significant 
difference in the content of lactic acid measured between 
the experimental group and the control group after add-
ing different levels of metformin, but different levels of 
metformin could promote cell proliferation. High glucose 
environment can inhibit the proliferation of liver cells, 
the reason may be that high glucose induces the expres-
sion of STC2 in liver cells, and overexpression of STC2 
can further enhance the proliferation inhibition ability of 
liver cells induced by high glucose [16]. In addition, high 
glucose has also been shown to promote the secretion 
of inflammatory cytokines such as TNF‐α, IL‐6, and 
regulate the expression of apoptosis-related molecules 
B lymphoma 2 and Bax, thereby inducing apoptosis of 
hepatocytes[17]. Metformin promotes the proliferation of 
hepatocytes, possibly because it inhibits the secretion of 
inflammatory cytokines and the activity of nuclear fac-
tor-κB (NF-κB) through AMPK-dependent pathways, so 
as to promote cell proliferation [18].
In conclusion, metformin has no significant effect on 
lactic acid metabolism of hepatocytes in high glucose en-
vironment, but different concentrations of metformin have 
a protective mechanism for hepatocytes and can promote 
cell proliferation.
References
[1] Mu Yiming, Ji Linong et al. Expert consensus on 
clinical application of metformin (2016 edition) [J]. 
Chinese Journal of Diabetes, 2016,24 (10) :871-884.
[2] Dang Yongyan, Ye Xiyun, Shen Jie. Journal of East 
China Normal University, 2010, (5) : 143-148. (in 
Chinese with English abstract)
[3] Su Hongwei, Wei Xun, Pan Hailin et al. Blood Lactic 
Acid Level and Its Influential Factors in Patients with 
Type 2 Diabetes [J]. Diabetes mellitus, 2015,32 (2) 
:215-218.
[4] NingGuang. The status and prospect of diabetes pre-
vention and treatment in China [J]. Science China 
(Life Sciences), 2018,48 (8) : 810-811.
[5] Lilian Beatriz Aguayo Rojas,Marilia Brito Gomes. 
Metformin: an old but still the best treatment for type 
2 diabetes[J]. Lilian Beatriz Aguayo Rojas;Marilia 
Brito Gomes,2013,5(1).
[6] Zhang Weina, Yu Min, Sun Meiyun, et al. Lactic ac-
idosis caused by metformin: a case report [J]. China 
Rural Medicine 2020,27(01),43-44.
[7] Qiu Y P. Be careful to take metformin in special pop-
ulation [J]. Shanghai Journal of Traditional Chinese 
Medicine 2019-08-09 004 Medication guidelines.
[8] Lin Jian, Zhou Zhiguang. Diagnosis, treatment and 
progress of diabetic lactic acidosis. Journal of Clini-
cal Internal Medicine, 2017, 34:159-161.
[9] Richy FF，Sabido-Espin M，Guedes S，et al． In-
cidence of lactic acidosis in patients with type 2 dia-
betes with and without renal impairment treated with 
metformin: a retrospective cohort study．Diabetes 
Care，2014，37(8) : 2291-2295．
[10] Aharaz A，Pottegard A，Henriksen DP，et al． 
Ｒ isk of lactic aci- dosis in type 2 diabetes patients 
using metformin: A case control study． PloS One，
2018，13(5) : e0196122．
[11] Xianbin Cai,Xi Hu,Bozhi Cai,et al．Metformin 
suppresses hepatocellular carcinoma cell growth 
through inductionof cell cycle G1/G0 phase arrest 
DOI: https://doi.org/10.30564/jer.v3i1.2864
31
Journal of Endocrinology Research | Volume 03 | Issue 01 | January 2021
Distributed under creative commons license 4.0
and p21CIP and p27KIP expression and downregu-
lationof cyclin D1 in vitro and in vivo[J]. Oncology 
Reports,2013,30(5).
[12] Guo Yali, Lu Shuming, Li Chunyan, Liu Lina. The 
relationship between insulin resistance and liv-
er function in patients with cirrhosis and diabetes 
mellitus [J]. Journal of Dalian Medical Universi-
ty,2017,39(04):378-382.
[13] Almirall J, Briculle M, Gonzalez clemente JM. Met-
formin-as-sociated lactic acidosis in type 2 diabetes 
mellitus : incidence and presentation in common 
elinical practice. Nephrol Dial Trans-plant , 2008 
,23:2436- 2438.
[14] Lu ZQ. The value of metguanidine hypoglycemic 
drugs in the treatment of type 2 diabetes mellitus [J]. 
Journal of Clinical Therapeutics,2010,8(04):33-38.
[15] McAlister FA, Majumdar SR, Eurich DT et al.The 
effect of specialist care within the first year on sub-
sequent outcomes in 24 232 adults with new-onset 
diabetes mellitus:population based cohort study [J].
Qual Saf Health Care,2007,16 ( 1) : 6 － 11．
[16] Tao Wenyu, Chen Jiaoli, Li Xiaojin, Xiong Yuxin, 
Hong Chao, Wang Xiaoling. Journal of Applied Med-
icine,2019,35(14):2220-2224+2229. 
[17] LI Yan-chen, HUANG Cai-bin, LIU Yao, XIA Wen-
yan, XU Rong. The role and mechanism of high 
mobility group protein B1 in human hepatocyte 
malignant transformation induced by high glucose 
microenvironment [J]. Chinese Journal of Diabe-
tes,2019,27(02):137-142.
[18] Li Z, Ding Q, Ling LP, et al.Metformin attenuates 
motility, contraction, and fibrogenic response of he-
patic stellate cells in vivo and in vitro by activating 
amp-activated protein kinase[J].World J Gastroenter-
ol, 2018, 24 (7) :819-832
DOI: https://doi.org/10.30564/jer.v3i1.2864
